[Therapy of hypertension. Cost conscious prevention of complications].
Kolloch
Rainer E
RE
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000191:economics* / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000191:economics* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D017046:Cost Savings / Q000639:trends; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D016527:Drug Costs / Q000639:trends*; D016568:Drugs, Generic / Q000191:economics* / Q000627:therapeutic use; D005544:Forecasting; D005858:Germany; D006801:Humans; D006852:Hydrochlorothiazide / Q000191:economics* / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications* / Q000191:economics*; D009313:National Health Programs / Q000191:economics*; D017257:Ramipril / Q000191:economics* / Q000627:therapeutic use; D016896:Treatment Outcome
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D004338:Drug Combinations; D016568:Drugs, Generic; D006852:Hydrochlorothiazide; D017257:Ramipril